Feasibility of randomised clinical trials in rare diseases: The case of polycythemia vera

Leukemia and Lymphoma

Volumn 22, Issue SUPPL. 1, 1996, Pages 121-127

  Marchioli, Roberto ^a,d   Landolfi, Raffaele ^c   Barbui, Tiziano ^b   Tognoni, Gianni ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d NONE   (Italy)

Author keywords

Polycythemia vera; Randomized clinical trials; Rare diseases

Indexed keywords

ANTIINFECTIVE AGENT; ANTITHROMBOCYTIC AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; MULTICENTER STUDY; PHLEBOTOMY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 0029859311     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609074369     Document Type: Review

References (19)

1. Anderson, D. R. (1991) Second Thoughts. Umbrellas and lions. J. Clin. Epidemiol., 44, 335-7.
2. Evidence-based Medicine Working Group. (1992) Evidence-based medicine: A new approach to teaching the practice of medicine. JAMA. 268, 2420-2425.
3. Sackett, K. D. L. (1995) Applying overviews and meta-analyses at the bedside. J. Clin. Epidemiol., 48, 61-66.
4. Chalmers, I. (1993) The Cochrane Collaboration: preparing, maintaining and disseminating systematic reviews of the effects of health care. Ann. N.Y. Acad. Sci., 703, 156-165.
5. Tognoni, G. and Bonati, M. (1986) Second-generation clinical pharmacology. Lancet., 2, 1028-29.
6. Tognoni, G., Franzosi, M. G., Garattini, S., Maggioni, A., Lotto, A. and Mauri, F. et al. (1990) The case of GISSI in changing the attitudes and practice of Italian Cardiologists. Stat. Med., 9, 17-27.
7. Gruppo Italiano per lo Studio della Streptokinasi nell'Infarto Miocardico (GISSI). (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet., 1, 397-402.
8. Antman, E. M., Lau, J., Kupelnick, B., Mosteller, F. and Chalmers, T. C. (1992) A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA, 268, 240-48.
9. Marchioli, R. (1993) Easy Meta-analysis? J. Nephrol, 6, 193-201.
10. Thompson, S. G. and Pocock, S. J. (1991) Can meta-analysis be trusted? Lancet., 338, 1127-30.
11. Miettinen, O. S. (1989) The clinical trial as a paradigm for epidemiologic research. J. Clin. Epidemiol., 42, 491-6.
12. Pocock, S. J. (1983) Clinical trials: A practical approach. Chichester: Wiley.
13. Peto, R., Pike, M. C., Armitage, P., Breslow, Ne., Cox, D. R., Howard, S. W., Mantel, N., McPherson, K., Peto, J. and Smith, P. G. (1976-1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Part I: Introduction and design. Br. J. Cancer, 34, 585-612. Part H: Analysis and examples. Br. J. Cancer, 35, 139.
14. Peto, R., Pike, M. C., Armitage, P., Breslow, Ne, Cox, D. R., Howard, S. W., Mantel, N., McPherson, K., Peto, J. and Smith, P. G. (1976-1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Part I: Introduction and design. Br. J. Cancer, 34, 585-612. Part H: Analysis and examples. Br. J. Cancer, 35, 139.
15. Yusuf, S., Collins, R. and Peto, R. (1984) Why do we need some large, simple randomized trials? Stat. Med., 3, 409-420.
16. Yusuf, S., Held, P., Teo, K. K. and Toretsky, E. R. (1990) Selection of patients for randomized controlled trials: implications of wide or narrow elegibility criteria. Stat. Med., 9, 73-86.
17. Marchioli, R., Prieto, J. C. and Tognoni, G. (1994) Surrogate end-points: the case of trials on coronary atherosclerotic plaque regression. Clin. Trials and Meta-Analysis, 29, 139-176.
18. Hennekens, C. H. and Buring, J. E. (1987) Epidemiology in medicine. Mayrent, S. L. Eds. Little, Brown and Company Boston, Massachusetts.
19. nd Edn. Boston: Little, Brown.